logo
ENTITY

Cadrenal Therapeutics (CVKD US)

3
Analysis
Health Care • United States
Cadrenal Therapeutics, Inc. operates as a biotech company. The Company focuses on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease, or ESRD, and atrial fibrillation. Cadrenal Therapeutics serves customers worldwide.
more
Company Event • 12 Mar 2025 21:30 • Upcoming
Add To Calendar

Q4 2024

Company Event • 08 Nov 2024 05:00 • Upcoming
Add To Calendar

Q3 2024

Company Event • 07 Aug 2024 20:00 • Upcoming
Add To Calendar

Q2 2024

Company Event • 09 May 2024 06:00 • Upcoming
Add To Calendar

Q1 2024

Company Event • 11 Mar 2024 07:00 • Upcoming
Add To Calendar

Q4 2023

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x